Note 15. Net Loss Per Share Basic and diluted net loss per share are as follows: | | | | | | | | | | | | | | | Three months ended | | Six months ended | | | June 30, | | June 30, | | | 2026 | | 2025 | | 2026 | | 2025 | | | | | | | | | | | | | | Net loss (numerator) | | $ | (14,713) | | $ | (19,187) | | $ | (27,404) | | $ | (26,441) | Weighted average shares (denominator) | | | 30,300 | | | 7,843 | | | 26,954 | | | 6,347 | Basic and diluted net loss per share | | $ | (0.49) | | $ | (2.45) | | $ | (1.02) | | $ | (4.17) |
Potentially dilutive securities outstanding consists of stock options, RSUs and performance units, and BTI warrants. The Company had common stock equivalents outstanding are as follows: | | | | | | | | | As of | | | June 30, | | | 2026 | | 2025 | | | | | | | | Stock options | | | 467 | | | 351 | Restricted stock units | | | 308 | | | 77 | Performance stock units | | | — | | | 57 | BTI Warrants | | | 7,860 | | | 5,479 | Total common stock equivalents | | | 8,635 | | | 5,964 |
|